Clinical Trials


NSABP B-42
 
Cancer Type: Breast
Description: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer
Entity Approving The Trial:
  National Surgical Adjuvant Breast and Bowel Project (NSABP)
Phase: III
Site-Wide Accrual Goal: 3,840
 
Related Files
No related files found.
 
Related Links
http://www.cancer.gov/search/viewclinicaltrials.aspx?version=healthprofessional&cdrid=502263